Fair Value Measurements (Tables)

6 Months Ended

Jul. 31, 2022

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows:

	Fair Value Measured as of July 31, 2022
	Level 1		Level 2		Level 3		Total
	(in thousands)
Assets
Money market funds	$	75,954	$	—	$	—	$	75,954
U.S. Treasury securities	—		283,880		—		283,880
Total financial assets	$	75,954	$	283,880	$	—	$	359,834
Liabilities
Contingent earnout liability recognized upon acquisition of ViriCiti (ViriCiti Earnout)	—		—		5,488		5,488
Total financial liabilities	$	—	$	—	$	5,488	$	5,488

	Fair Value Measured as of January 31, 2022
	Level 1		Level 2		Level 3		Total
	(in thousands)
Assets
Money market funds	$	254,716	$	—	$	—	$	254,716
Total financial assets	$	254,716	$	—	$	—	$	254,716
Liabilities
Common stock warrant liabilities (Private Placement)	$	—	$	—	$	25	$	25
Contingent earnout liability recognized upon acquisition of ViriCiti (ViriCiti Earnout)	—		—		5,993		5,993
Total financial liabilities	$	—	$	—	$	6,018	$	6,018

Summary of Changes in the Fair Value of the Company's Level 3 Financial Instruments

The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments:

	Private placement warrant liability		ViriCiti Earnout liability
	(in thousands)
Fair value as of January 31, 2022	$	(25)	$	(5,993)
Change in fair value included in other income (expense), net	(23)		—
Effect of foreign currency translation	—		505
Reclassification of warrants to stockholders’ equity (deficit) due to exercise	48		—
Fair value as of July 31, 2022	$	—	$	(5,488)

	Redeemable convertible preferred stock warrant liability		Private placement warrant liability		Earnout liability
	(in thousands)
Fair value as of January 31, 2021	$	(75,843)	$	—	$	—
Private placement warrant liability acquired as part of the merger	—		(127,888)		—
Contingent earnout liability recognized upon the closing of the reverse recapitalization	—		—		(828,180)
Change in fair value included in other income (expense), net	9,237		49,264		84,420
Reclassification of warrants to stockholders’ equity (deficit) due to exercise	—		51,756		—
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse capitalization	66,606		—		—
Issuance of earnout shares upon triggering events	—		—		501,120
Reclassification of remaining contingent earnout liability upon triggering event	—		—		242,640
Fair value as of July 31, 2021	$	—	$	(26,868)	$	—